Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Ataluren

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 24,728Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PTC Therapeutics Updates on Translarna in Europe
    PTC Therapeutics Updates on Translarna in Europe

    28 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-regulatory-update-on-translarna-ataluren-in-europe-302414288.html

    PR NEWSWIRE
    28 Mar 2025
    Share Share
    CHMP Maintains Negative Opinion on Translarna™ Reexamination
    CHMP Maintains Negative Opinion on Translarna™ Reexamination

    18 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chmp-maintains-negative-opinion-on-translarna-reexamination-302279958.html

    PR NEWSWIRE
    18 Oct 2024
    Share Share
    PTC Therapeutics Reports Q2 2024 Results And Corporate Update
    PTC Therapeutics Reports Q2 2024 Results And Corporate Update

    08 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-corporate-update-and-reports-second-quarter-2024-financial-results-302218200.html

    PR NEWSWIRE
    08 Aug 2024
    Share Share
    EMA committee recommends non-renewal conditional marketing authorisation of DMD
    EMA committee recommends non-renewal conditional marketing authorisation of DMD

    12 Jul 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=171262&sid=2

    PHARMABIZ
    12 Jul 2024
    Share Share
    CHMP Issues Negative Opinion On Translarna Following European Commission Review
    CHMP Issues Negative Opinion On Translarna Following European Commission Review

    28 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chmp-issues-negative-opinion-on-translarna-following-european-commission-request-for-review-302185263.html

    PR NEWSWIRE
    28 Jun 2024
    Share Share
    PTC's re-examination bid for Translarna falls short in Europe
    PTC's re-examination bid for Translarna falls short in Europe

    25 Jan 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/ptcs-re-examination-bid-dmd-drug-translarna-falls-short-europe

    FIERCE PHARMA
    25 Jan 2024
    Share Share